AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-KSEP 32 min read$PDEX

PRO DEX INC (PDEX): Quarter Ended June 30, 2026

PRO DEX INC (PDEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Richard L. Van Kirk, Chief Executive Officer (949) 769-3200 For Immediate Release PRO-DEX, INC. ANNOUNCES FISCAL 2026 FOURTH QUARTER AND FULL-YEAR RESULTS IRVINE, CA, September 3, 2026 - PRO-DEX, INC. (NasdaqCM: PDEX) t oday announced financial results for i

Original reporting
SEC EDGAR 8-K
Published Sep 3, 2026, 8:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 9:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$PDEX
Bullish
high confidence
Mentioned
$PDEX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PDEXBullishMed
01

Why it matters

The earnings beat and margin improvement provide a fresh catalyst for traders, while expense growth tempers enthusiasm.

02

Market read

First‑time earnings disclosure for a micro‑cap medical device company, offering a modest trading opportunity.

03

What to watch

Volatility from marketable equity investments and integration risks of the APM acquisition.

Relevance 7/10Novelty 7/10Timing: filed Sep 3, 2026

Background

Pro‑Dex, a Nasdaq Capital Market listed medical device maker, filed its quarterly earnings via an 8‑K filing.

Company-level read

Ticker impact

$PDEXBullishHigh confidence
Context

SEC Form 8‑K reports Pro‑Dex's Q4 and full‑year 2026 results, showing 17% revenue growth and a 35% gross margin.

Expected impact

Potential short‑term price rally of 5‑8% if market digests the beat.

Evidence & confidence

First‑time disclosure of earnings with solid top‑line growth and improved margins provides actionable insight.

Market effects

Sector

Positive earnings may boost sentiment in the medical device and orthopedic equipment sector.

Regional

Limited to U.S. small‑cap market; no broader regional effect.

Global

Minimal global impact beyond niche medical device investors.

Counterpoint

What could challenge this read

Higher operating expenses and reliance on a single large customer could pressure margins if demand wanes.

Key entities

  • Executive
    Richard L. Van Kirk

    CEO of Pro‑Dex who commented on the results.

  • Subsidiary
    Advanced Precision Machining, LLC (APM)

    Recent acquisition contributing to revenue and expenses.

Read at source← All news

Related articles

OCT 16
$MANMedAI 8/10

Manpower Announces New CEO, Only Fifth In Its History

ManpowerGroup (MAN) announced Becky Frankiewicz as its next CEO, effective January 1, 2027. She will succeed Jonas Prising, who will become executive chair. The company reported Q3 2026 revenue of $4.84B, up 4.4%, and net earnings of $34.1M, nearly doubling from the prior year. The transition follows a long-term succession plan, with Frankiewicz currently serving as president and chief strategy officer.

urbanmilwaukee.com2 min
OCT 16
$JPMMed

Jamie Dimon Warns Americans Could Pay the Price if the Fed Keeps Rates High for Too Long — ‘We Just Don’t Know When’ the Good Times Will End

JPMorgan Chase (JPM) reported a rare profit miss with net income of $15.3B ($5.57 per share) on revenue of $50.91B, missing expectations. CEO Jamie Dimon warned about potential economic risks, including a rise in the 10-year Treasury yield to 6%, and emphasized preparedness for various outcomes. The bank added 650,000 net new checking accounts and maintained its top position in U.S. retail deposits.

finance.yahoo.com2 min